Ethanol is a widely used solvent in the pharmaceutical industry. Borregaard's bioethanol is produced by fermentation of lignocellulosic waste and has a highly favourable carbon footprint. Compared with synthetic ethanol, Borregaard’s bioethanol enables your company to reduce scope 3 emissions considerably.
Reduce scope 3 emissions by using bioethanol in the pharmaceutical industry
Borregaard's bioethanol is classified as advanced ethanol as it is naturally derived from lignocellulosic waste, specifically brown sulphite liquor. With a GHG reduction of 86-95% compared to synthetic ethanol, Borregaard's wood-based bioethanol is a greener alternative that can help your company reduce its emissions and achieve its Scope 3 reduction goals.
Borregaard's bioethanol is COSMOS, Kosher, Ecocert, and ISCC certified, and our manufacturing process does not use antibiotics or GMOs.
For more information, please visit our certifications page.
If you want to learn more about how much you can reduce your Scope 3 emissions by using our bioethanol in pharmaceuticals, please try our Scope 3 calculator.